Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Latest filing published 20 Jan 2026 for Nkarta, Inc., €46k. Read the official filing
Filing timeline
BuySalePaul J. Hastings
Insider track record
Disclosed buys
0
Disclosed sells
28
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Paul J. Hastings: trading record in brief
Filings by Paul J. Hastings span 4 companies, the busiest being Pacira BioSciences, Inc., Nkarta, Inc. and OncoMed Pharmaceuticals Inc. We count 54 filings; the first trade dates from 6 January 2016 and the latest from 15 January 2026.
Sales make up the whole of the open-market record (28 sales, €1.8M). The rest of the record consists of 18 share grants and 5 option exercises. Since January 2026: no purchases and 1 sale on the market.
The latest filing, published on 20 January 2026, reports an open-market sale of €46k in Nkarta, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Paul J. Hastings
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
26,046 shares@ US$2.074.5% of flowCommon StockSEC:0001193125-26-016865:0
94,000 shares0Common StockSEC:0001193125-26-007896:0
1,790 shares@ US$1.790.3% of flowCommon StockSEC:0000950170-25-088501:0
17,378 shares@ US$2.202.9% of flowCommon StockSEC:0000950170-25-006824:0
94,500 shares0Common StockSEC:0000950170-25-002827:0
1,770 shares@ US$5.600.7% of flowCommon StockSEC:0000950170-24-075732:0
5,230 shares0Common StockSEC:0001396814-24-000075:0
12,358 shares@ US$13.0011.7% of flowCommon StockSEC:0000950170-24-026055:0
9,697 shares@ US$8.746.1% of flowCommon StockSEC:0000950170-24-005426:0
85,000 shares0Common StockSEC:0001209191-24-001160:0
1,704 shares@ US$4.850.6% of flowCommon StockSEC:0001209191-23-039051:0
1,775 shares0Common StockSEC:0001209191-23-038023:0
580 shares@ US$38.3396.7% of flowCommon StockSEC:0001209191-23-035257:0
7,000 shares@ US$29.9062.5% of flowCommon StockSEC:0001209191-23-030141:0
64,500 shares0Common StockSEC:0001209191-23-003853:0
23,376 shares@ US$13.031124.7% of flowCommon StockSEC:0000899243-22-032306:0
6,126 shares@ US$13.01296.4% of flowCommon StockSEC:0000899243-22-031711:0
533 shares@ US$56.959.8% of flowCommon StockSEC:0001209191-22-042037:0
19,500 shares0Common StockSEC:0001209191-22-038532:0
1,160 shares0Common StockSEC:0001209191-22-035223:0
41,900 shares0Common StockSEC:0001209191-22-003759:0
8,277 shares@ US$27.2019.0% of flowCommon StockSEC:0000899243-21-038637:0
4,693 shares@ US$26.3910.2% of flowCommon StockSEC:0000899243-21-025505:0
1,066 shares0Common StockSEC:0001209191-21-040084:0
630 shares@ US$62.1911.7% of flowCommon StockSEC:0001209191-21-038878:0
25 of 27 declarations
